539730
FREDUN
Start SIP
Invest Now
Start SIP in FREDUN
Performance
- Low
- ₹1,731
- High
- ₹1,944
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,999
- Open Price₹1,750
- Previous Close₹1,783
- Volume19,442
- 50 DMA₹1,611.93
- 100 DMA₹1,534.64
- 200 DMA₹1,346.43
Investment Returns
- Over 1 Month + 31.66%
- Over 3 Month + 16.16%
- Over 6 Month + 78.6%
- Over 1 Year + 157.91%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 26.2
- PEG Ratio
- 0.3
- Market Cap Cr
- 893
- P/B Ratio
- 5.7
- Average True Range
- 107.91
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 13.01
- RSI
- 73.68
- MFI
- 82.99
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,892.00
+
109.15
(6.12%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹1,637.72
- 50 Day
- ₹1,611.93
- 100 Day
- ₹1,534.64
- 200 Day
- ₹1,346.43
Resistance and Support
1852.5
- R3 2,187.00
- R2 2,065.50
- R1 1,974.00
- S1 1,761.00
- S2 1,639.50
- S3 1,548.00
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-09 | Quarterly Results | |
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹1,892 As on 12 February, 2026 | 02:12
The Market Cap of Fredun Pharmaceuticals is ₹893.3 Cr As on 12 February, 2026 | 02:12
The P/E ratio of Fredun Pharmaceuticals is 26.2 As on 12 February, 2026 | 02:12
The PB ratio of Fredun Pharmaceuticals is 5.7 As on 12 February, 2026 | 02:12
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.